1-4 of 4
Jong Chul Park
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors

Gregory M. Cote, Bose S. Kochupurakkal, Khanh Do, Andrea Bullock, Michael L. Cheng, Alona Muzikansky, Daniel E. McLoughlin, James M. Cleary, Xin Gao, Aparna Parikh, Jong Chul Park, Colin D. Weekes, Oladapo Yeku, Lee Zou, Geoffrey I. Shapiro
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (1): 35–44.
https://doi.org/10.1158/1078-0432.CCR-24-1867
Published: 06 January 2025
View article titled, A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors
Open the PDF for A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

Catherine H. Marshall, Wei Fu, Hao Wang, Jong Chul Park, Theodore L. DeWeese, Phuoc T. Tran, Daniel Y. Song, Serina King, Michaella Afful, Julia Hurrelbrink, Charlotte Manogue, Patrick Cotogno, Nancy P. Moldawer, Pedro C. Barata, Charles G. Drake, Edwin M. Posadas, Andrew J. Armstrong, Oliver Sartor, Emmanuel S. Antonarakis
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (6): 1623–1630.
https://doi.org/10.1158/1078-0432.CCR-20-4476
Published: 15 March 2021
View article titled, Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer
Open the PDF for Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

MSH2 Loss in Primary Prostate Cancer

Liana B. Guedes, Emmanuel S. Antonarakis, Michael T. Schweizer, Nooshin Mirkheshti, Fawaz Almutairi, Jong Chul Park, Stephanie Glavaris, Jessica Hicks, Mario A. Eisenberger, Angelo M. De Marzo, Jonathan I. Epstein, William B. Isaacs, James R. Eshleman, Colin C. Pritchard, Tamara L. Lotan
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (22): 6863–6874.
https://doi.org/10.1158/1078-0432.CCR-17-0955
Published: 14 November 2017
View article titled, MSH2 Loss in Primary Prostate Cancer
Open the PDF for MSH2 Loss in Primary Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157

Noah M. Hahn, Trinity J. Bivalacqua, Ashley E. Ross, George J. Netto, Alex Baras, Jong Chul Park, Carolyn Chapman, Timothy A. Masterson, Michael O. Koch, Richard Bihrle, Richard S. Foster, Thomas A. Gardner, Liang Cheng, David R. Jones, Kyle McElyea, George E. Sandusky, Timothy Breen, Ziyue Liu, Costantine Albany, Marietta L. Moore, Rhoda L. Loman, Angela Reed, Scott A. Turner, Francine B. De Abreu, Torrey Gallagher, Gregory J. Tsongalis, Elizabeth R. Plimack, Richard E. Greenberg, Daniel M. Geynisman
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (12): 3003–3011.
https://doi.org/10.1158/1078-0432.CCR-16-2267
Published: 14 June 2017
View article titled, A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <em>FGFR3</em> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
Open the PDF for A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <em>FGFR3</em> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157 in another window
Includes: Supplementary data